YHB Investment Advisors Inc. Invests $232,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

YHB Investment Advisors Inc. acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 390 shares of the biotechnology company’s stock, valued at approximately $232,000.

Other large investors have also recently added to or reduced their stakes in the company. Public Sector Pension Investment Board grew its holdings in shares of Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after acquiring an additional 500 shares in the last quarter. CIBC Asset Management Inc boosted its position in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC purchased a new position in Axon Enterprise in the third quarter valued at about $221,000. Sequoia Financial Advisors LLC increased its position in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $814,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 5.4 %

Shares of AXON stock opened at $637.53 on Wednesday. The stock has a 50 day moving average of $618.29 and a 200-day moving average of $476.64. The firm has a market cap of $48.61 billion, a PE ratio of 164.74, a price-to-earnings-growth ratio of 6.09 and a beta of 1.04. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $247.04 and a 12 month high of $698.67.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This trade represents a 34.52 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 in the last ninety days. 6.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently commented on AXON. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price for the company. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.